The tumors derived from co-injecting GFP-N and I-Red cells exhibited aggressive glioblastoma characteristics including hemorrhaging, invasion, and necrosis (Fig. 2b), along with high expression of stem cell markers including Nestin, CD133, and GFP (Fig. 2c). The gene discussed is PROM1; the disease is glioblastoma.